Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-03-14
1988-04-26
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 530331, 4352402, 43524021, A61K 3702, C12N 502
Patent
active
047405015
ABSTRACT:
The cancericidal activity of all the permutations of a tripeptide compound formed from dichlorodiethylaminophenylalanine, parafluorophenylalanine and methionine bonded together with peptide links was demonstrated using seven in vitro tumor cell lines. The viabilities of each of the tumor cell lines were significantly reduced by treatment for 1 to 24 hours with 1 to 50 ug of the tripeptide per ml of carrier solvent. A pulse exposure to the tripeptide demonstrated that the reductions in tumor cell was comparable to continuous exposure. Other in vitro tests were all conducted on AKR mice.
Method of treating virus by exposing the virus to one of the noted tripeptides compounds is also contemplated.
Methods of treating tumor cells with the tripeptides dissolved in a solvent consisting of dimethylacetamide, propylene glycol and absolute ethanol are also contemplated by the present invention.
Methods of treating tumor cells resistant to other chemotherapeutic agents is contemplated by this invention.
Methods of treating mouse mammary tumor cells to reduce production of the B-type retrovirus, mouse mammary tumor virus (MMTV), is contemplated by this invention.
REFERENCES:
patent: 4087520 (1978-05-01), Bran et al.
patent: 4127534 (1978-11-01), Coy et al.
patent: 4153688 (1979-05-01), Demecoli et al.
patent: 4540683 (1985-09-01), DeBarbieri et al.
Bekesi Julius G.
DeBarbieri Augusto
LandOfFree
Interference of b-type retrovirus replication with a tripeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interference of b-type retrovirus replication with a tripeptide , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interference of b-type retrovirus replication with a tripeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-819618